Lexaria Bioscience Corp.
LEXXNASDAQHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $5.09M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.46$14.37
- Volume (live)
- -
- Avg. volume (3M)
- 74.05K
Lexaria Bioscience (LEXX) Stock Price & Financial Analysis
Lexaria Bioscience Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $2.84 - $3.20 |
|---|---|
| 52-Week High | $14.37 |
| 52-Week Low | $0.46 |
| Open | $2.98 |
| Volume (last close) | 23.23K |
| Average Volume (3M) | 74.05K |
| Revenue (TTM) | 194.00K |
|---|---|
| Net Income (TTM) | -7.73M |
| Free Cash Flow (TTM) | -7.53M |
| EPS (TTM) | −$5.14 |
| Profit Margin | -3985.58% |
| Operating Margin | -3973.16% |
| Return on Equity (ROE) | -163.18% |
| Debt to Equity | 0.02 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 5.09M |
|---|---|
| Shares Outstanding | 1.65M |
| Price to Sales (P/S) | 26.26 |
| Price to Book (P/B) | 1.07 |
| EV/EBITDA | -0.21 |
| 50-Day MA | $6.23 |
|---|---|
| 200-Day MA | $4.74 |
| 1-Year Change | +228.57% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Lexaria Bioscience at a Glance
As of the Oct 23, 2026 close, Lexaria Bioscience (LEXX) has a market capitalization of $5.09M. The stock trades at 26.3× sales. Over the trailing twelve months it lost $7.73M on revenue of $194.00K and burned $7.53M of free cash flow. Revenue fell 68.5% year over year.
As of its latest reported balance sheet, it holds $3.48M in cash and securities against $86.71K of debt, a net cash position of $3.39M.
Lexaria Bioscience does not currently pay a dividend.
The share price is up 228.6% over the past year. At $3.08 (the Oct 23, 2026 close) it sits within its 52-week range of $0.46 to $14.37, below its 200-day moving average of $4.74.
Frequently Asked Questions About Lexaria Bioscience
What is the current stock price for LEXX?
As of the Oct 23, 2026 close, LEXX stock trades at $3.08. The 52-week range is $0.46–$14.37, with a day range of $2.84–$3.20.
What is the P/E ratio for LEXX?
The P/E ratio (Price-to-Earnings) for LEXX is shown in the Key Statistics section. This valuation metric helps compare Lexaria Bioscience Corp. to industry peers.
Does LEXX pay dividends?
Lexaria Bioscience does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for LEXX?
Analyst ratings and recommendations for LEXX are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of LEXX?
As of the Oct 23, 2026 close, Lexaria Bioscience's market capitalization is $5.1M, classifying it as a micro-cap company. Lexaria Bioscience operates in the Healthcare sector within the Biotechnology industry.